InnoCan Pharma Corporation
InnoCan Pharma Corporation (INNPF) Stock Competitors & Peer Comparison
See (INNPF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INNPF | $0.16 | +0.00% | 48.1M | -16.44 | -$0.01 | N/A |
| MKGAF | $125.00 | -1.69% | 55.7B | 16.83 | $7.62 | +1.95% |
| MKKGY | $24.96 | -0.24% | 55.7B | 16.64 | $1.50 | +2.01% |
| HLNCF | $4.69 | -4.09% | 43.4B | 23.02 | $0.21 | +1.80% |
| TKPHF | $27.50 | +0.55% | 43B | 48.25 | $0.57 | +4.84% |
| IPSEY | $30.42 | -7.82% | 40.3B | 24.53 | $1.24 | +0.85% |
| SDZNY | $56.99 | -0.04% | 24.4B | -2830.50 | -$0.02 | +1.19% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.00 | +0.00% | 16.1B | -93.33 | -$0.15 | N/A |
| SGIOY | $8.55 | +2.64% | 14.5B | 12.72 | $0.67 | +1.87% |
Stock Comparison
INNPF vs MKGAF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, MKGAF has a market cap of 55.7B. Regarding current trading prices, INNPF is priced at $0.16, while MKGAF trades at $125.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas MKGAF's P/E ratio is 16.83. In terms of profitability, INNPF's ROE is -0.13%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, INNPF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check MKGAF's competition here
INNPF vs MKKGY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, MKKGY has a market cap of 55.7B. Regarding current trading prices, INNPF is priced at $0.16, while MKKGY trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas MKKGY's P/E ratio is 16.64. In terms of profitability, INNPF's ROE is -0.13%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, INNPF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check MKKGY's competition here
INNPF vs HLNCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HLNCF has a market cap of 43.4B. Regarding current trading prices, INNPF is priced at $0.16, while HLNCF trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HLNCF's P/E ratio is 23.02. In terms of profitability, INNPF's ROE is -0.13%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, INNPF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HLNCF's competition here
INNPF vs TKPHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, TKPHF has a market cap of 43B. Regarding current trading prices, INNPF is priced at $0.16, while TKPHF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas TKPHF's P/E ratio is 48.25. In terms of profitability, INNPF's ROE is -0.13%, compared to TKPHF's ROE of +0.01%. Regarding short-term risk, INNPF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check TKPHF's competition here
INNPF vs IPSEY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, IPSEY has a market cap of 40.3B. Regarding current trading prices, INNPF is priced at $0.16, while IPSEY trades at $30.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas IPSEY's P/E ratio is 24.53. In terms of profitability, INNPF's ROE is -0.13%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, INNPF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check IPSEY's competition here
INNPF vs SDZNY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SDZNY has a market cap of 24.4B. Regarding current trading prices, INNPF is priced at $0.16, while SDZNY trades at $56.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SDZNY's P/E ratio is -2830.50. In terms of profitability, INNPF's ROE is -0.13%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, INNPF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check SDZNY's competition here
INNPF vs ESALY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, INNPF is priced at $0.16, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas ESALY's P/E ratio is 20.54. In terms of profitability, INNPF's ROE is -0.13%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, INNPF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check ESALY's competition here
INNPF vs TEVJF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, TEVJF has a market cap of 16.1B. Regarding current trading prices, INNPF is priced at $0.16, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas TEVJF's P/E ratio is -93.33. In terms of profitability, INNPF's ROE is -0.13%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, INNPF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check TEVJF's competition here
INNPF vs SGIOY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SGIOY has a market cap of 14.5B. Regarding current trading prices, INNPF is priced at $0.16, while SGIOY trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SGIOY's P/E ratio is 12.72. In terms of profitability, INNPF's ROE is -0.13%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, INNPF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check SGIOY's competition here
INNPF vs SGIOF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, INNPF is priced at $0.16, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SGIOF's P/E ratio is 12.44. In terms of profitability, INNPF's ROE is -0.13%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, INNPF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check SGIOF's competition here
INNPF vs SFOSF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SFOSF has a market cap of 10.3B. Regarding current trading prices, INNPF is priced at $0.16, while SFOSF trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SFOSF's P/E ratio is 17.80. In terms of profitability, INNPF's ROE is -0.13%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, INNPF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check SFOSF's competition here
INNPF vs BIOVF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, INNPF is priced at $0.16, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas BIOVF's P/E ratio is 22.74. In terms of profitability, INNPF's ROE is -0.13%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, INNPF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check BIOVF's competition here
INNPF vs IPSEF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, INNPF is priced at $0.16, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas IPSEF's P/E ratio is 22.95. In terms of profitability, INNPF's ROE is -0.13%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, INNPF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check IPSEF's competition here
INNPF vs ESALF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, ESALF has a market cap of 8.2B. Regarding current trading prices, INNPF is priced at $0.16, while ESALF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas ESALF's P/E ratio is 26.13. In terms of profitability, INNPF's ROE is -0.13%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, INNPF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check ESALF's competition here
INNPF vs ESAIY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, ESAIY has a market cap of 8.1B. Regarding current trading prices, INNPF is priced at $0.16, while ESAIY trades at $7.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas ESAIY's P/E ratio is 25.39. In terms of profitability, INNPF's ROE is -0.13%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, INNPF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check ESAIY's competition here
INNPF vs GZPHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, GZPHF has a market cap of 5.8B. Regarding current trading prices, INNPF is priced at $0.16, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas GZPHF's P/E ratio is 10.22. In terms of profitability, INNPF's ROE is -0.13%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, INNPF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check GZPHF's competition here
INNPF vs HKMPF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HKMPF has a market cap of 5.8B. Regarding current trading prices, INNPF is priced at $0.16, while HKMPF trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HKMPF's P/E ratio is 16.38. In terms of profitability, INNPF's ROE is -0.13%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, INNPF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HKMPF's competition here
INNPF vs HKMPY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HKMPY has a market cap of 5.7B. Regarding current trading prices, INNPF is priced at $0.16, while HKMPY trades at $51.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HKMPY's P/E ratio is 16.05. In terms of profitability, INNPF's ROE is -0.13%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, INNPF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HKMPY's competition here
INNPF vs SGFEF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, INNPF is priced at $0.16, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SGFEF's P/E ratio is 24.91. In terms of profitability, INNPF's ROE is -0.13%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, INNPF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check SGFEF's competition here
INNPF vs WIBFF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, INNPF is priced at $0.16, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, INNPF's ROE is -0.13%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, INNPF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check WIBFF's competition here
INNPF vs HLUBF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HLUBF has a market cap of 4.4B. Regarding current trading prices, INNPF is priced at $0.16, while HLUBF trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HLUBF's P/E ratio is 9.30. In terms of profitability, INNPF's ROE is -0.13%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, INNPF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HLUBF's competition here
INNPF vs HLBBF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HLBBF has a market cap of 4.1B. Regarding current trading prices, INNPF is priced at $0.16, while HLBBF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HLBBF's P/E ratio is 10.10. In terms of profitability, INNPF's ROE is -0.13%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, INNPF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HLBBF's competition here
INNPF vs SMDPY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SMDPY has a market cap of 3.9B. Regarding current trading prices, INNPF is priced at $0.16, while SMDPY trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SMDPY's P/E ratio is 24.48. In terms of profitability, INNPF's ROE is -0.13%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, INNPF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check SMDPY's competition here
INNPF vs LVZPF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, LVZPF has a market cap of 3.6B. Regarding current trading prices, INNPF is priced at $0.16, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, INNPF's ROE is -0.13%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, INNPF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check LVZPF's competition here
INNPF vs CHSYF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, INNPF is priced at $0.16, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CHSYF's P/E ratio is 15.00. In terms of profitability, INNPF's ROE is -0.13%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, INNPF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CHSYF's competition here
INNPF vs ULIHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, INNPF is priced at $0.16, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, INNPF's ROE is -0.13%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, INNPF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check ULIHF's competition here
INNPF vs APNHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, INNPF is priced at $0.16, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas APNHF's P/E ratio is 12.95. In terms of profitability, INNPF's ROE is -0.13%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, INNPF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check APNHF's competition here
INNPF vs INVVY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, INNPF is priced at $0.16, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas INVVY's P/E ratio is -62.42. In terms of profitability, INNPF's ROE is -0.13%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, INNPF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check INVVY's competition here
INNPF vs IZQVF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, INNPF is priced at $0.16, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, INNPF's ROE is -0.13%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, INNPF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check IZQVF's competition here
INNPF vs DNPUF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, INNPF is priced at $0.16, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, INNPF's ROE is -0.13%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, INNPF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check DNPUF's competition here
INNPF vs LBTSF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, INNPF is priced at $0.16, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas LBTSF's P/E ratio is 121.45. In terms of profitability, INNPF's ROE is -0.13%, compared to LBTSF's ROE of +0.02%. Regarding short-term risk, INNPF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check LBTSF's competition here
INNPF vs HYPMY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, INNPF is priced at $0.16, while HYPMY trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HYPMY's P/E ratio is 19.74. In terms of profitability, INNPF's ROE is -0.13%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, INNPF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HYPMY's competition here
INNPF vs APNHY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, APNHY has a market cap of 2.8B. Regarding current trading prices, INNPF is priced at $0.16, while APNHY trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas APNHY's P/E ratio is 11.39. In terms of profitability, INNPF's ROE is -0.13%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, INNPF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check APNHY's competition here
INNPF vs HMDCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, INNPF is priced at $0.16, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, INNPF's ROE is -0.13%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, INNPF is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HMDCF's competition here
INNPF vs THCBF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, INNPF is priced at $0.16, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas THCBF's P/E ratio is -0.10. In terms of profitability, INNPF's ROE is -0.13%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, INNPF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check THCBF's competition here
INNPF vs DMPHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, INNPF is priced at $0.16, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, INNPF's ROE is -0.13%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, INNPF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check DMPHF's competition here
INNPF vs HTSUF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, INNPF is priced at $0.16, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HTSUF's P/E ratio is 16.17. In terms of profitability, INNPF's ROE is -0.13%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, INNPF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HTSUF's competition here
INNPF vs LJUIF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, INNPF is priced at $0.16, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, INNPF's ROE is -0.13%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, INNPF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check LJUIF's competition here
INNPF vs ARSUF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, INNPF is priced at $0.16, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, INNPF's ROE is -0.13%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, INNPF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check ARSUF's competition here
INNPF vs TSMRF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, INNPF is priced at $0.16, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas TSMRF's P/E ratio is 8.24. In terms of profitability, INNPF's ROE is -0.13%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, INNPF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check TSMRF's competition here
INNPF vs YIHCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, YIHCF has a market cap of 1.8B. Regarding current trading prices, INNPF is priced at $0.16, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, INNPF's ROE is -0.13%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, INNPF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check YIHCF's competition here
INNPF vs NPNKF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, INNPF is priced at $0.16, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas NPNKF's P/E ratio is 7.87. In terms of profitability, INNPF's ROE is -0.13%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, INNPF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check NPNKF's competition here
INNPF vs CASBF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CASBF has a market cap of 1.6B. Regarding current trading prices, INNPF is priced at $0.16, while CASBF trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CASBF's P/E ratio is -25.33. In terms of profitability, INNPF's ROE is -0.13%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, INNPF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CASBF's competition here
INNPF vs MITPF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, INNPF is priced at $0.16, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas MITPF's P/E ratio is -10.81. In terms of profitability, INNPF's ROE is -0.13%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, INNPF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check MITPF's competition here
INNPF vs GTBIF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, INNPF is priced at $0.16, while GTBIF trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas GTBIF's P/E ratio is 31.71. In terms of profitability, INNPF's ROE is -0.13%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, INNPF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check GTBIF's competition here
INNPF vs KARBF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, INNPF is priced at $0.16, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas KARBF's P/E ratio is 262.50. In terms of profitability, INNPF's ROE is -0.13%, compared to KARBF's ROE of N/A. Regarding short-term risk, INNPF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check KARBF's competition here
INNPF vs EVOTF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, INNPF is priced at $0.16, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas EVOTF's P/E ratio is -6.26. In terms of profitability, INNPF's ROE is -0.13%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, INNPF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check EVOTF's competition here
INNPF vs NPPNY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, INNPF is priced at $0.16, while NPPNY trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas NPPNY's P/E ratio is 6.52. In terms of profitability, INNPF's ROE is -0.13%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, INNPF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check NPPNY's competition here
INNPF vs SHEZF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, INNPF is priced at $0.16, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, INNPF's ROE is -0.13%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, INNPF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check SHEZF's competition here
INNPF vs CHIZF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, INNPF is priced at $0.16, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, INNPF's ROE is -0.13%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, INNPF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CHIZF's competition here
INNPF vs GNMLF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, INNPF is priced at $0.16, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, INNPF's ROE is -0.13%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, INNPF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check GNMLF's competition here
INNPF vs SWGHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, INNPF is priced at $0.16, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, INNPF's ROE is -0.13%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, INNPF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check SWGHF's competition here
INNPF vs KSPHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, INNPF is priced at $0.16, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas KSPHF's P/E ratio is 14.66. In terms of profitability, INNPF's ROE is -0.13%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, INNPF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check KSPHF's competition here
INNPF vs CURLF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CURLF has a market cap of 1.1B. Regarding current trading prices, INNPF is priced at $0.16, while CURLF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CURLF's P/E ratio is -4.33. In terms of profitability, INNPF's ROE is -0.13%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, INNPF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CURLF's competition here
INNPF vs KKPCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, INNPF is priced at $0.16, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, INNPF's ROE is -0.13%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, INNPF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check KKPCF's competition here
INNPF vs NIKA Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, NIKA has a market cap of 972.9M. Regarding current trading prices, INNPF is priced at $0.16, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas NIKA's P/E ratio is N/A. In terms of profitability, INNPF's ROE is -0.13%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, INNPF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check NIKA's competition here
INNPF vs BIOGY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, BIOGY has a market cap of 960.3M. Regarding current trading prices, INNPF is priced at $0.16, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas BIOGY's P/E ratio is 33.62. In terms of profitability, INNPF's ROE is -0.13%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, INNPF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check BIOGY's competition here
INNPF vs SHPHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, INNPF is priced at $0.16, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, INNPF's ROE is -0.13%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, INNPF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check SHPHF's competition here
INNPF vs TCNNF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, TCNNF has a market cap of 886.6M. Regarding current trading prices, INNPF is priced at $0.16, while TCNNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas TCNNF's P/E ratio is -5.87. In terms of profitability, INNPF's ROE is -0.13%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, INNPF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check TCNNF's competition here
INNPF vs LVTTF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, LVTTF has a market cap of 886M. Regarding current trading prices, INNPF is priced at $0.16, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, INNPF's ROE is -0.13%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, INNPF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check LVTTF's competition here
INNPF vs EVRRF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, EVRRF has a market cap of 882.2M. Regarding current trading prices, INNPF is priced at $0.16, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, INNPF's ROE is -0.13%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, INNPF is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check EVRRF's competition here
INNPF vs NRXCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, NRXCF has a market cap of 838.3M. Regarding current trading prices, INNPF is priced at $0.16, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, INNPF's ROE is -0.13%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, INNPF is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check NRXCF's competition here
INNPF vs TWAPF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, INNPF is priced at $0.16, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, INNPF's ROE is -0.13%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, INNPF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check TWAPF's competition here
INNPF vs SWDCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, SWDCF has a market cap of 773.6M. Regarding current trading prices, INNPF is priced at $0.16, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas SWDCF's P/E ratio is 121.00. In terms of profitability, INNPF's ROE is -0.13%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, INNPF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check SWDCF's competition here
INNPF vs CSWYF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, INNPF is priced at $0.16, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, INNPF's ROE is -0.13%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, INNPF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CSWYF's competition here
INNPF vs TRXPF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, INNPF is priced at $0.16, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, INNPF's ROE is -0.13%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, INNPF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check TRXPF's competition here
INNPF vs TRSSF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, INNPF is priced at $0.16, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, INNPF's ROE is -0.13%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, INNPF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check TRSSF's competition here
INNPF vs AIHLF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, AIHLF has a market cap of 543.1M. Regarding current trading prices, INNPF is priced at $0.16, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, INNPF's ROE is -0.13%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, INNPF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check AIHLF's competition here
INNPF vs PKBFF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, PKBFF has a market cap of 541.2M. Regarding current trading prices, INNPF is priced at $0.16, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas PKBFF's P/E ratio is N/A. In terms of profitability, INNPF's ROE is -0.13%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, INNPF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check PKBFF's competition here
INNPF vs CCHWF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, INNPF is priced at $0.16, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, INNPF's ROE is -0.13%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, INNPF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check CCHWF's competition here
INNPF vs ELTP Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, ELTP has a market cap of 515.7M. Regarding current trading prices, INNPF is priced at $0.16, while ELTP trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas ELTP's P/E ratio is -24.08. In terms of profitability, INNPF's ROE is -0.13%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, INNPF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check ELTP's competition here
INNPF vs BOIRF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, INNPF is priced at $0.16, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, INNPF's ROE is -0.13%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, INNPF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check BOIRF's competition here
INNPF vs PEXXF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, INNPF is priced at $0.16, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, INNPF's ROE is -0.13%, compared to PEXXF's ROE of N/A. Regarding short-term risk, INNPF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check PEXXF's competition here
INNPF vs KHTRF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, KHTRF has a market cap of 446.4M. Regarding current trading prices, INNPF is priced at $0.16, while KHTRF trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas KHTRF's P/E ratio is 64.00. In terms of profitability, INNPF's ROE is -0.13%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, INNPF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check KHTRF's competition here
INNPF vs AGYTF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, INNPF is priced at $0.16, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, INNPF's ROE is -0.13%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, INNPF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check AGYTF's competition here
INNPF vs HUMDF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, INNPF is priced at $0.16, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, INNPF's ROE is -0.13%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, INNPF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HUMDF's competition here
INNPF vs GLASF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, GLASF has a market cap of 287.6M. Regarding current trading prices, INNPF is priced at $0.16, while GLASF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas GLASF's P/E ratio is -60.22. In terms of profitability, INNPF's ROE is -0.13%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, INNPF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check GLASF's competition here
INNPF vs BHCCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, BHCCF has a market cap of 271.6M. Regarding current trading prices, INNPF is priced at $0.16, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, INNPF's ROE is -0.13%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, INNPF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check BHCCF's competition here
INNPF vs VRNOF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, VRNOF has a market cap of 233.8M. Regarding current trading prices, INNPF is priced at $0.16, while VRNOF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas VRNOF's P/E ratio is -0.65. In terms of profitability, INNPF's ROE is -0.13%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, INNPF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check VRNOF's competition here
INNPF vs CPHRF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CPHRF has a market cap of 225.1M. Regarding current trading prices, INNPF is priced at $0.16, while CPHRF trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CPHRF's P/E ratio is 24.41. In terms of profitability, INNPF's ROE is -0.13%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, INNPF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CPHRF's competition here
INNPF vs CRLBF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CRLBF has a market cap of 202.9M. Regarding current trading prices, INNPF is priced at $0.16, while CRLBF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CRLBF's P/E ratio is -2.50. In terms of profitability, INNPF's ROE is -0.13%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, INNPF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CRLBF's competition here
INNPF vs PLNHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, INNPF is priced at $0.16, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, INNPF's ROE is -0.13%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, INNPF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check PLNHF's competition here
INNPF vs PHCUF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, INNPF is priced at $0.16, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas PHCUF's P/E ratio is 600.00. In terms of profitability, INNPF's ROE is -0.13%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, INNPF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check PHCUF's competition here
INNPF vs CBWTF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CBWTF has a market cap of 131.9M. Regarding current trading prices, INNPF is priced at $0.16, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CBWTF's P/E ratio is 4.94. In terms of profitability, INNPF's ROE is -0.13%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, INNPF is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CBWTF's competition here
INNPF vs COPHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, INNPF is priced at $0.16, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas COPHF's P/E ratio is -0.02. In terms of profitability, INNPF's ROE is -0.13%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, INNPF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check COPHF's competition here
INNPF vs STMH Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, STMH has a market cap of 124.9M. Regarding current trading prices, INNPF is priced at $0.16, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas STMH's P/E ratio is N/A. In terms of profitability, INNPF's ROE is -0.13%, compared to STMH's ROE of -2.75%. Regarding short-term risk, INNPF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check STMH's competition here
INNPF vs NWPN Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, INNPF is priced at $0.16, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas NWPN's P/E ratio is -0.04. In terms of profitability, INNPF's ROE is -0.13%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, INNPF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check NWPN's competition here
INNPF vs LOVFF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, LOVFF has a market cap of 122.5M. Regarding current trading prices, INNPF is priced at $0.16, while LOVFF trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas LOVFF's P/E ratio is 13.40. In terms of profitability, INNPF's ROE is -0.13%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, INNPF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check LOVFF's competition here
INNPF vs HLTRF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, HLTRF has a market cap of 116.5M. Regarding current trading prices, INNPF is priced at $0.16, while HLTRF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas HLTRF's P/E ratio is -6.49. In terms of profitability, INNPF's ROE is -0.13%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, INNPF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check HLTRF's competition here
INNPF vs JUSHF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, JUSHF has a market cap of 111.5M. Regarding current trading prices, INNPF is priced at $0.16, while JUSHF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas JUSHF's P/E ratio is -2.27. In terms of profitability, INNPF's ROE is -0.13%, compared to JUSHF's ROE of +1.06%. Regarding short-term risk, INNPF is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check JUSHF's competition here
INNPF vs LPCUF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, INNPF is priced at $0.16, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, INNPF's ROE is -0.13%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, INNPF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check LPCUF's competition here
INNPF vs CNVCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, INNPF is priced at $0.16, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, INNPF's ROE is -0.13%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, INNPF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check CNVCF's competition here
INNPF vs GRUSF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, GRUSF has a market cap of 95.9M. Regarding current trading prices, INNPF is priced at $0.16, while GRUSF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas GRUSF's P/E ratio is -12.90. In terms of profitability, INNPF's ROE is -0.13%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, INNPF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check GRUSF's competition here
INNPF vs BIOYF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, BIOYF has a market cap of 93.3M. Regarding current trading prices, INNPF is priced at $0.16, while BIOYF trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas BIOYF's P/E ratio is 16.60. In terms of profitability, INNPF's ROE is -0.13%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, INNPF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check BIOYF's competition here
INNPF vs LRDSF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, LRDSF has a market cap of 83.5M. Regarding current trading prices, INNPF is priced at $0.16, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, INNPF's ROE is -0.13%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, INNPF is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check LRDSF's competition here
INNPF vs AAWH Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, AAWH has a market cap of 79.7M. Regarding current trading prices, INNPF is priced at $0.16, while AAWH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas AAWH's P/E ratio is -0.97. In terms of profitability, INNPF's ROE is -0.13%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, INNPF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check AAWH's competition here
INNPF vs ABSCF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, ABSCF has a market cap of 77.4M. Regarding current trading prices, INNPF is priced at $0.16, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, INNPF's ROE is -0.13%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, INNPF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check ABSCF's competition here
INNPF vs EOFBY Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, INNPF is priced at $0.16, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, INNPF's ROE is -0.13%, compared to EOFBY's ROE of N/A. Regarding short-term risk, INNPF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for INNPF.Check EOFBY's competition here
INNPF vs ORXOF Comparison August 2025
INNPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INNPF stands at 48.1M. In comparison, ORXOF has a market cap of 69.7M. Regarding current trading prices, INNPF is priced at $0.16, while ORXOF trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INNPF currently has a P/E ratio of -16.44, whereas ORXOF's P/E ratio is -3.16. In terms of profitability, INNPF's ROE is -0.13%, compared to ORXOF's ROE of +2.89%. Regarding short-term risk, INNPF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for INNPF.Check ORXOF's competition here